Hetero’s Generics Ibrutinib Receives Tentative Approval in US
16 Apr 2026 //
FDA
Mankind’s Generics Brimonidine Tartrate Receives Approval in US
16 Apr 2026 //
FDA
Baxter’s Generics Dexmedetomidine HCl Receives Approval in US
15 Apr 2026 //
FDA
Qilu’s Generics Sugammadex Receives Tentative Approval in US
15 Apr 2026 //
FDA
Aurobindo’s Generics Dextromethorphan Receives Approval in US
15 Apr 2026 //
FDA
Teva’s Generics Glycerol Phenylbutyrate Receives Approval in US
15 Apr 2026 //
FDA
Edenbridge’s Generics Atropine Sulfate Receives Approval in US
15 Apr 2026 //
FDA
Msn’s Generics Glycerol Phenylbutyrate Receives Approval in US
15 Apr 2026 //
FDA
Alembic’s Generics Methotrexate Na Receives Approval in US
15 Apr 2026 //
FDA
Aspiro’s Generics Sodium Bicarbonate Receives Approval in US
15 Apr 2026 //
FDA
Apotex’s Generics Canagliflozin Receives Approval in US
14 Apr 2026 //
FDA
Micro’s Generics Olmesartan Medoxomil Receives Approval in US
13 Apr 2026 //
FDA
Novitium Pharma’s Generics Pimozide Receives Approval in US
13 Apr 2026 //
FDA
Apotex’s Generics Multiple Vitamins Inj Receives Approval in US
09 Apr 2026 //
FDA
Inventia’s Generics Dapagliflozin Receives Tentative Nod in US
09 Apr 2026 //
FDA
Aucta’s Generics Fosfomycin Tromethamine Receives Approval in US
09 Apr 2026 //
FDA
Ascent’ Generics Mirabegron Receives Tentative Approval in US
09 Apr 2026 //
FDA
Micro’s Generics Ofloxacin Receives Approval in US
08 Apr 2026 //
FDA
Glenmark Pharms’ Generics Progesterone Receives Approval in US
08 Apr 2026 //
FDA
Renata’s Generics Bempedoic Receives Tentative Approval in US
08 Apr 2026 //
FDA
Zenara’s Generics Eltrombopag Olamine Receives Approval in US
08 Apr 2026 //
FDA
Changzhou’s Generics Verquvo Receives Tentative Approval in US
08 Apr 2026 //
FDA
Macleod’s Generics Emtricitabine, Tenofovir Receives Nod in US
07 Apr 2026 //
FDA
Ajanta Pharma’s Generics Ivermectin Receives Approval in US
07 Apr 2026 //
FDA
Creekwood Pharms’ Generics Nitrofurantoin Receives Approval in US
07 Apr 2026 //
FDA
Apotex’s Generics Semaglutide Receives Tentative Approval in US
07 Apr 2026 //
FDA
Sandoz’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Micro’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Aurobindo Pharma’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Bion Pharma’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
MSN’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
MSN’s Generics Dapagliflozin & Metformin Receives Approval in US
06 Apr 2026 //
FDA
Aizant’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Lupin’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Msn’s Generics Dapagliflozin & Saxagliptin Receive Approval in US
06 Apr 2026 //
FDA
Cipla’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Cipla’s Generics Dapagliflozin & Metformin Receive Approval in US
06 Apr 2026 //
FDA
Torrent’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Macleods’ Generics Dapagliflozin & Metformin Receives nod in US
06 Apr 2026 //
FDA
Teva’ Generics Dapagliflozin And Metformin Receives nod in US
06 Apr 2026 //
FDA
Micro’s Generics Dapagliflozin & Metformin Receives Nod in US
06 Apr 2026 //
FDA
Sun Pharm’s Generics Dapagliflozin & Metformin Receives Nod in US
06 Apr 2026 //
FDA
Alkem’s Generics Dapagliflozin & Metformin Receives Nod in US
06 Apr 2026 //
FDA
Lupin’s Generics Dapagliflozin & Metformin Receives Nod in US
06 Apr 2026 //
FDA
Padagis’ Generics Glycopyrronium Tosylate Receives Approval in US
03 Apr 2026 //
FDA
Baxter’s Generics Phenylephrine HCl Receives Approval in US
03 Apr 2026 //
FDA
Apotex’s Generics Nintedanib Esylate Receives Approval in US
02 Apr 2026 //
FDA
Dexcel’s Generics Nintedanib Esylate Receives Approval in US
02 Apr 2026 //
FDA
Cipla’s Generics Nintedanib Esylate Receives Approval in US
02 Apr 2026 //
FDA
Dr Reddy’s Generics Nintedanib Esylate Receives Approval in US
02 Apr 2026 //
FDA
Eli Lilly And’s Foundayo Receives Approval in US
01 Apr 2026 //
FDA
Lupin’s Generics Sugammadex Receives Tentative Approval in US
26 Mar 2026 //
FDA
Sagent’s Generics Norepinephrine Receives Approval in US
26 Mar 2026 //
FDA
Glenmark’ Generics Nintedanib Receives Tentative Approval in US
26 Mar 2026 //
FDA
Teva’s Generics Nintedanib Receives Tentative Approval in US
26 Mar 2026 //
FDA
Natco’s Generics Cabozantinib Receives Tentative Approval in US
25 Mar 2026 //
FDA
Inventia’s Generics Sitagliptin Receives Tentative Approval in US
25 Mar 2026 //
FDA
Encube’s Generics Tretinoin Receives Approval in US
25 Mar 2026 //
FDA
Corcept Therap’s Lifyorlitm Receives Approval in Us
25 Mar 2026 //
FDA
Sun’s Generics Pomalidomide Receives Tentative Approval in US
24 Mar 2026 //
FDA
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.